Asiaticoside is one of the major triterpene saponin compounds found in Centella asiatica. Asiaticoside is mainly extracted from the dried whole grass of C. asiatica. Asiaticoside offers a wide range of pharmacological properties, including neuroprotective, cardioprotective, hepatoprotective, wound-healing, anti-inflammatory, antioxidant, antiallergic, antidepressant, anxiolytic, antifibrotic, antibacterial, antiarthritic, antitumor, and immunomodulatory activities. Asiaticoside is also used extensively in treating skin abnormalities, burn injuries, ischemia, ulcers, asthma, lupus, psoriasis, and scleroderma. Besides medicinal applications, phytocompounds like asiaticoside are considered cosmetically beneficial for their role in anti-ageing, skin hydration, collagen synthesis, ultraviolet (UV) protection, and curing scars.
Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.
Please note: Due to the complexity and amount of studies regarding this compound—a Natural Health Product—increased cost is charged.
OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:
To order an OEL/ADE monograph for Asiaticoside, just click the ADD TO CART button.
If you're wondering about HBEL, we have something for you.
Not the compound you were looking for? You can search the OEL Fastrac catalog to find more available compounds.
Affygility Solutions’ OEL Fastrac service is an user-friendly system that enables us to make confident decisions and focus on moving the compound safely through our facility. We can quickly access the database to determine if a new drug is within the OEL Fastrac library, and if so, immediately download a detailed OEL banding report. The OEL Fastrac system has been a helpful tool in our overall EH&S program.